Platform
Pipeline
Patients
Investors
About Us
- About Us
- Meet the Team
News
Contact

Platform
Pipeline
Patients
Investors
About Us
- About Us
- Meet the Team
News
Contact

Platform
Pipeline
Patients
Investors
About Us
- About Us
- Meet the Team
News
Contact

November 2019

IONIQ Sciences / 2019 / November

ProLung Announces Change to its Board of Directors

ProLung Announces Change to its Board of Directors Salt Lake City, UT, November 26, 2019 –...

Categories

Awards and Recognition
News
Uncategorized

Search

Search for:

Latest News

IONIQ’s new LUNA3 is a Winner 07/01/2022
IONIQ Unveils LUNA3, Next-Generation Early-Stage Cancer Detection Platform 06/23/2022
IONIQ Presents Lung Cancer Trial Results at ATS 2022 05/23/2022

Archive

cancer testing modernized

Not available for sale in the USA

Latest News

IONIQ’s new LUNA3 is a Winner
IONIQ Unveils LUNA3, Next-Generation Early-Stage Cancer Detection Platform
IONIQ Presents Lung Cancer Trial Results at ATS 2022
IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

Twitter Feed

IONIQ Sciences, Inc. and our LUNA3 next-gen platform for early-stage cancer detection is a #winner! Giant thank you… https://t.co/NWVRZqN3ne

18 hours ago
The #LGBTQ+ community suffers disparities in access to and quality of #cancer care. This is one reason why we're w… https://t.co/NlTcM7O4zL

2 weeks ago
RT @BioHiveUtah: .@IoniqSciences is modernizing cancer detection to dramatically improve the cancer landscape. We are proud to have IONIQ i…

3 weeks ago

Subscribe to our Newsletter

First Name

Last Name

Email address:

Leave this field empty if you're human:

ProLung, Inc. dba IONIQ Sciences Copyright 2020. All Rights Reserved - Privacy Policy - Terms and Conditions